0001209191-22-050094.txt : 20220915
0001209191-22-050094.hdr.sgml : 20220915
20220915170013
ACCESSION NUMBER: 0001209191-22-050094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220913
FILED AS OF DATE: 20220915
DATE AS OF CHANGE: 20220915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giberson Scott
CENTRAL INDEX KEY: 0001937585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39871
FILM NUMBER: 221246354
MAIL ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001833214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 853899721
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
BUSINESS PHONE: 605-679-6980
MAIL ADDRESS:
STREET 1: 2100 EAST 54TH STREET NORTH
CITY: SIOUX FALLS
STATE: SD
ZIP: 57104
FORMER COMPANY:
FORMER CONFORMED NAME: Big Cypress Acquisition Corp.
DATE OF NAME CHANGE: 20201120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-13
0
0001833214
SAB Biotherapeutics, Inc.
SABS
0001937585
Giberson Scott
2100 EAST 54TH STREET NORTH
SIOUX FALLS
SD
57104
1
0
0
0
Employee Stock Option (right to buy)
0.71
2022-09-13
4
A
0
25000
0.00
A
2032-09-13
Common Stock
25000
25000
D
Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
The shares underlying the option vest over a three-year period, vesting 1/36 monthly beginning with the month following the Reporting Person's commencement of service as a director (July 6, 2022). This represents the initial grant to the Reporting Person as a member of the Board of Directors.
/s/ Scott Giberson
2022-09-15